William R Larue Tracon Pharmaceuticals, Inc. (TCON) insider trading activity

TCON Quotes by TradingView

William R Larue is Director of Tracon Pharmaceuticals, Inc.. Currently has a direct ownership of 7,763 shares of TCON, which is worth approximately $232. The most recent transaction as insider was on Dec 21, 2022, when has been sold 120 shares (Common Stock) at a price of $1.26 per share, resulting in proceeds of $151. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.76K
0% 3M change
0% 12M change
Total Value Held $232

WILLIAM R LARUE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2022
SELL
Open market or private sale
$151 $1.26 p/Share
120 Reduced 1.52%
7,763 Common Stock
Jul 26 2021
BUY
Open market or private purchase
$25,002 $3.82 p/Share
6,545 Added 45.36%
7,883 Common Stock

Also insider at

ONCT
Oncternal Therapeutics, Inc. Healthcare
WRL

William R Larue

Director
San Diego, CA

Track Institutional and Insider Activities on TCON

Follow Tracon Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCON shares.

Notify only if

Insider Trading

Get notified when an Tracon Pharmaceuticals, Inc. insider buys or sells TCON shares.

Notify only if

News

Receive news related to Tracon Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCON